Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Zymeworks IncCommon Stock stock (ZYME)

Buy Zymeworks IncCommon Stock stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

Zymeworks IncCommon Stock is a biotechnology business based in the US. Zymeworks IncCommon Stock shares (ZYME) are listed on the NASDAQ and all prices are listed in US Dollars. Zymeworks IncCommon Stock employs 275 staff and has a trailing 12-month revenue of around $50.5 million.

Our top picks for where to buy Zymeworks IncCommon Stock stock

Top pick for advanced traders

Go to site
Get up to $5,000 cash
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Our pick for transfer bonus

Go to site
Get up to $10,000 cash
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options, with no options contract fees
  • No-cost financial planning and automated investing

Our pick for Investing by theme

Go to site
Earn up to $300 on new deposits
  • Trade $0 commission stocks & ETFs with as little as $1
  • Theme and ETF screener
  • Discover new opportunities with Opto's AI-driven classification system

How to buy Zymeworks IncCommon Stock stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – ZYME. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Zymeworks IncCommon Stock stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 5 of 5
Name Product Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Tastytrade
Finder Score: 4.4 / 5: ★★★★★
Tastytrade
★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
$0
$0
N/A
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
SoFi Invest®
Finder Score: 4.2 / 5: ★★★★★
SoFi Invest®
★★★★★
Stocks, Options, Mutual funds, ETFs, Alternatives
$0
$0
0.02%
Get up to $10,000 cash
Commission-free stocks, ETFs and options, with no options per-contract fees. Plus, a no-cost robo-advisor and complimentary access to certified financial planners (CFPs).
OPTO
Finder Score: 3.1 / 5: ★★★★★
OPTO
★★★★★
Stocks, ETFs
$0
$0
N/A
Earn up to $300
AI-driven thematic investing, with proprietary research, fractional shares and commission-free stocks and ETFs.
Moomoo
Finder Score: 4.3 / 5: ★★★★★
Exclusive
Moomoo
★★★★★
Stocks, Options, ETFs
$0
$0
Up to 8.10%
Get up to 15 free stocks
No commission stock, ETF and options trades, with $0 equity options contract fees, low margin rates and advanced trading tools.
Public.com
Finder Score: 4.2 / 5: ★★★★★
Public.com
★★★★★
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
$0
$0
5.1%
Get up to $10,000 and transfer fees covered
Build a diversified portfolio of stocks, bonds, options, ETFs, crypto and alternative assets, with a high-yield cash account and options contract rebates.
loading

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Zymeworks IncCommon Stock stock price (NASDAQ: ZYME)

Use our graph to track the performance of ZYME stocks over time.

Zymeworks IncCommon Stock shares at a glance

Information last updated 2024-07-21.
Latest market close$10.26
52-week range$6.02 - $13.14
50-day moving average $8.99
200-day moving average $9.33
Wall St. target price$14.36
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-1.78

Is it a good time to buy Zymeworks IncCommon Stock stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Zymeworks IncCommon Stock price performance over time

Historical closes compared with the close of $10.26 from 2024-07-22

1 week (2024-07-16) -0.87%
1 month (2024-06-21) 22.00%
3 months (2024-04-23) 19.86%
6 months (2024-01-23) -0.19%
1 year (2023-07-21) 30.37%
2 years (2022-07-22) 76.29%
3 years (2021-07-23) 35.44
5 years (2019-07-23) 24.31

Zymeworks IncCommon Stock financials

Revenue TTM $50.5 million
Gross profit TTM $203.8 million
Return on assets TTM -16.15%
Return on equity TTM -27.64%
Profit margin -249.63%
Book value $6.20
Market Capitalization $691.5 million

TTM: trailing 12 months

Zymeworks IncCommon Stock share dividends

We're not expecting Zymeworks IncCommon Stock to pay a dividend over the next 12 months.

Zymeworks IncCommon Stock share price volatility

Over the last 12 months, Zymeworks IncCommon Stock's shares have ranged in value from as little as $6.015 up to $13.14. A popular way to gauge a stock's volatility is its "beta".

ZYME.US volatility(beta: 1.14)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Zymeworks IncCommon Stock's is 1.143. This would suggest that Zymeworks IncCommon Stock's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Zymeworks IncCommon Stock overview

Zymeworks Inc. , a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a human epidermal growth factor receptor 2 (HER2) that is in Phase 1, Phase 2, and Phase 3 clinical trials, including certain ongoing pivotal clinical trials; and zanidatamab zovodotin, a HER2 -targeted antibody-drug conjugate that is in Phase 2 clinical trial for the treatment of advanced or metastatic HER2-expressing tumors. It also develops a pipeline of preclinical product candidates and discovery-stage programs in oncology, including immuno-oncology agents and other therapeutic areas. Zymeworks Inc. has strategic partnerships and collaborations with BeiGene, Ltd. ; Celgene Corporation; Celgene Alpine Investment Co.

Frequently asked questions

What percentage of Zymeworks IncCommon Stock is owned by insiders or institutions?
Currently 4.031% of Zymeworks IncCommon Stock shares are held by insiders and 98.145% by institutions.
How many people work for Zymeworks IncCommon Stock?
Latest data suggests 275 work at Zymeworks IncCommon Stock.
When does the fiscal year end for Zymeworks IncCommon Stock?
Zymeworks IncCommon Stock's fiscal year ends in December.
Where is Zymeworks IncCommon Stock based?
Zymeworks IncCommon Stock's address is: 108 Patriot Drive, Middletown, DE, United States, 19709
What is Zymeworks IncCommon Stock's ISIN number?
Zymeworks IncCommon Stock's international securities identification number is: CA98985W1023
What is Zymeworks IncCommon Stock's CUSIP number?
Zymeworks IncCommon Stock's Committee on Uniform Securities Identification Procedures number is: 98985W102

More guides on Finder

Ask a question

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site